VIRTUSSIN A/C- codeine phosphate and guaifenesin liquid United States - English - NLM (National Library of Medicine)

virtussin a/c- codeine phosphate and guaifenesin liquid

unit dose services - codeine phosphate (unii: gsl05y1mn6) (codeine anhydrous - unii:ux6owy2v7j), guaifenesin (unii: 495w7451vq) (guaifenesin - unii:495w7451vq) - - temporarily relieves: cough due to minor throat and bronchial irritation as may occur with a cold or inhaled irritants your cough to help you sleep helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive. - cough due to minor throat and bronchial irritation as may occur with a cold or inhaled irritants - your cough to help you sleep - helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive.

VIRTUSSIN A/C- codeine phosphate and guaifenesin liquid United States - English - NLM (National Library of Medicine)

virtussin a/c- codeine phosphate and guaifenesin liquid

proficient rx lp - codeine phosphate (unii: gsl05y1mn6) (codeine anhydrous - unii:ux6owy2v7j), guaifenesin (unii: 495w7451vq) (guaifenesin - unii:495w7451vq) -

VIRTUSSIN A/C- codeine phosphate and guaifenesin liquid United States - English - NLM (National Library of Medicine)

virtussin a/c- codeine phosphate and guaifenesin liquid

a-s medication solutions - codeine phosphate (unii: gsl05y1mn6) (codeine anhydrous - unii:ux6owy2v7j), guaifenesin (unii: 495w7451vq) (guaifenesin - unii:495w7451vq) - - temporarily relieves: cough due to minor throat and bronchial irritation as may occur with a cold or inhaled irritants your cough to help you sleep helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive. - cough due to minor throat and bronchial irritation as may occur with a cold or inhaled irritants - your cough to help you sleep - helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive.

Embryo-assessment microscope camera system application software Australia - English - Department of Health (Therapeutic Goods Administration)

embryo-assessment microscope camera system application software

virtus health - 61196 - embryo-assessment microscope camera system application software - the device is intended to provide clinical decision support for embryo assessment. the device evaluates early embryo development through acquired embryo time lapse images/videos to assist embryo selection during assisted reproduction. the device is intended as an adjunct to clinical decisions. the final assessment and decision shall be made by the embryologist.

KETOROLAC TROMETHAMINE injection, solution United States - English - NLM (National Library of Medicine)

ketorolac tromethamine injection, solution

medical purchasing solutions, llc - ketorolac tromethamine (unii: 4eve5946bq) (ketorolac - unii:yzi5105v0l) - carefully consider the potential benefits and risks of ketorolac tromethamine and other treatment options before deciding to use ketorolac. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). acute pain in adult patients ketorolac tromethamine is indicated for the short-term (≤5 days) management of moderately severe acute pain that requires analgesia at the opioid level, usually in a postoperative setting. therapy should always be initiated with intravenous or intramuscular dosing of ketorolac tromethamine, and oral ketorolac tromethamine is to be used only as continuation treatment, if necessary. the total combined duration of use of ketorolac tromethamine injection and oral ketorolac tromethamine is not to exceed 5 days of use because of the potential of increasing the frequency and severity of adverse reactions associated with the recommended doses (see warnings, precautions, dosage and administr

KETOROLAC TROMETHAMINE tablet, film coated United States - English - NLM (National Library of Medicine)

ketorolac tromethamine tablet, film coated

nucare pharmaceuticals,inc. - ketorolac tromethamine (unii: 4eve5946bq) (ketorolac - unii:yzi5105v0l) - carefully consider the potential benefits and risks of ketorolac tromethamine tablets, usp and other treatment options before deciding to use ketorolac tromethamine tablets. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals. acute pain in adult patients ketorolac tromethamine tablets are indicated for the short-term (≤ 5 days) management of moderately severe acute pain that requires analgesia at the opioid level, usually in a postoperative setting. therapy should always be initiated with ketorolac tromethamine-iv or im and ketorolac tromethamine tablets are to be used only as continuation treatment, if necessary. the total combined duration of use of ketorolac tromethamine-iv/im and ketorolac tromethamine tablets is not to exceed 5 days of use because of the potential of increasing the frequency and severity of adverse reactions associated with the recommended doses (see warnings, precautions, dosage and administra

KETOROLAC TROMETHAMINE tablet, film coated United States - English - NLM (National Library of Medicine)

ketorolac tromethamine tablet, film coated

nucare pharmaceuticals,inc. - ketorolac tromethamine (unii: 4eve5946bq) (ketorolac - unii:yzi5105v0l) - carefully consider the potential benefits and risks of ketorolac tromethamine tablets, usp and other treatment options before deciding to use ketorolac tromethamine tablets. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals. acute pain in adult patients ketorolac tromethamine tablets are indicated for the short-term (≤ 5 days) management of moderately severe acute pain that requires analgesia at the opioid level, usually in a postoperative setting. therapy should always be initiated with ketorolac tromethamine-iv or im and ketorolac tromethamine tablets are to be used only as continuation treatment, if necessary. the total combined duration of use of ketorolac tromethamine-iv/im and ketorolac tromethamine tablets is not to exceed 5 days of use because of the potential of increasing the frequency and severity of adverse reactions associated with the recommended doses (see warnings, precautions, dosage and administra